Nutex Health Inc. NUTX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 47.5%-1.3pp | 50.8%+9.9pp | 55%+31.8pp | 51.4%+32.1pp | 48.8%+33.3pp | |
| Operating margin | 31.4%-2.2pp | 31.5%+4.3pp | 36.6%+39.9pp | 30.1%+37.4pp | 33.6%+43.6pp | |
| Net margin | 11%-0.9pp | 8.1%-2.8pp | 12.3%+26.4pp | 7.1%+20.9pp | 11.8%+27.7pp | |
| EBITDA margin | 33.8%-3.0pp | 33.8%+2.7pp | 38.7%+35.7pp | 32.7%+33.4pp | 36.8%+39.9pp | |
| Free cash flow margin | 30.6%+19.4pp | 28.1%+23.6pp | 18%+11.1pp | 10.6%+5.8pp | 11.2%— | |
| Returns | ||||||
| Return on equity | 35.5%-21.2pp | 30.7%-23.2pp | 63.9%+119pp | 37.9%+86.7pp | 56.7%+109pp | |
| Return on assets | 11.2%-1.4pp | 9%-0.9pp | 17.2%+26.2pp | 8.9%+17.8pp | 12.6%+22.5pp | |
| Return on invested capital | 45.6%+0.3pp | 44%+13.4pp | 70.7%+73.5pp | 48.3%+54.5pp | 45.3%+53.4pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 1.1×+0.2× | 1.4×+0.8× | 1.3×+0.6× | 1.1×+0.5× | |
| Liquidity | ||||||
| Current ratio | 3.1×+0.9× | 3.4×+1.5× | 3.2×+1.4× | 2.4×+0.8× | 2.3×+0.6× | |
| Quick ratio | 3.1×+0.9× | 3.4×+1.5× | 3.2×+1.4× | 2.4×+0.9× | 2.3×+0.6× | |
| Cash ratio | 1.1×+0.7× | 1.2×+0.9× | 0.9×+0.2× | 0.5×-0.1× | 0.5×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1×-0.7× | 1.1×-1.5× | 1.1×-3.8× | 1.4×-3.1× | 1.7×-2.6× | |
| Debt-to-assets | 0.4×-0.1× | 0.4×-0.1× | 0.4×-0.3× | 0.4×-0.3× | 0.4×-0.2× | |
| Net debt / EBITDA | 0.5×— | 0.6×— | 0.5×— | 0.9×— | —— | |
| Interest coverage | 13.3×+3.6× | 12.4×+5.8× | 16.1×+16.6× | 10.7×+11.8× | 9.7×+11.2× | |
| Valuation | ||||||
| Market capitalization | $1.02B+62.2% | $1.16B+576% | $573.95M+422% | $640.73M+2,066% | $255.7M+258% | |
| Enterprise value | $1.15B+32.0% | $1.33B+184% | $761.2M+110% | $881.38M+221% | $505.21M+62.4% | |
| Price / earnings | 10.5×+2.0× | 16.4×— | 4.8×— | —— | —— | |
| Price / sales | 1.2×+0.2× | 1.3×+1.0× | 0.6×+0.2× | 0.8×+0.7× | 0.4×+0.1× | |
| Price / book | 3×-0.2× | 3.5×+2.2× | 1.8×0.0× | 2.7×+2.3× | 1.3×+0.2× | |
| EV / EBITDA | 3.9×+0.1× | 4.5×— | 2×— | 3.4×— | —— | |
| EV / sales | 1.3×-0.1× | 1.5×+0.5× | 0.8×-0.5× | 1.1×+0.1× | 0.8×-0.4× | |
| Free cash flow yield | 26.2%+15.2pp | 21.1%+8.8pp | 30.8%+12.4pp | 13%-31.5pp | 27.3%— | |
| Earnings yield | 9.4%-2.3pp | 6.1%-24.2pp | 21%+58.4pp | 8.8%+137pp | 28.8%+86.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nutex Health Inc.'s profit margins?
- Nutex Health Inc. (NUTX) runs a 47.5% gross margin and a 31.4% operating margin, with a 11.0% net margin.
- Where do Nutex Health Inc.'s ratios come from?
- Every ratio is computed from Nutex Health Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
